carboplatin 中文意思是什麼

carboplatin 解釋
順二氨環丁烷羧酸鉑
  1. Carboplatin, a drug deried from cisplatin, is approed by fda

    Fda批準順鉑的衍生物-卡鉑
  2. Carboplatin, a drug derived from cisplatin, is approved by fda

    Fda批準順鉑的衍生物-卡鉑
  3. Treatment of malignant thoracic hydrops by carboplatin combined with new type interleukin

    2治療惡性胸腔積液
  4. The trial compared the effectiveness of avastin plus carboplatin and paclitaxel with chemotherapy by carboplatin and paclitaxel alone

    試驗中用阿瓦斯丁聯合卡鉑和紫杉醇化療和單用卡鉑和紫杉醇化療效果進行對比。
  5. The median overall survival time for patients in the avastin plus carboplatin and paclitaxel arm was 12. 3 months versus 10. 3 months for patients receiving only carboplatin and paclitaxel

    阿瓦斯丁聯合卡鉑和紫杉醇的平均生存時間為12 . 3個月，與之相對的單用卡鉑和紫杉醇的為10 . 3個月。
  6. Conclusions the addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non ? small - cell lung cancer has a significant survival benefit with the risk of increased treatment - related deaths. ( clinicaltrials. gov number, nct00021060 [ clinicaltrials. gov ]

    結論：紫杉醇-卡鉑加上貝伐單抗治療非小細胞肺癌，可明顯延長生存期，但治療相關性死亡風險也同時升高。
  7. In this thesis, the deposition properties and the release behavior after deposition of a low molecular model drug ( rhodamine b ) and four kinds of anti - cancer drugs ( daunorubicin ( dnr ), adroamycin ( adm ), cisplatin and carboplatin ) have been examined

    本文還研究了小分子模型藥物（羅丹明b ， rdb ）和四種抗癌藥物（順鉑， cisplatin ；卡鉑， carboplatin ；柔紅黴素， dnr ；阿黴素， adm ）在聚電解質微膠囊中的自發沉積和釋放性能。
  8. New york ( reuters health ) jan 15 - for chemotherapy - naie adanced oarian cancer patients, gemcitabine plus carboplatin yields response rates comparable to that of paclitaxel plus carboplatin, with a " more acceptable toxicity profile, " researchers from singapore report

    紐約（路透社健康專欄） 1月15號訊-新加坡的研究人員報告說，用化學療法治療晚期卵巢癌， 2 ， 2 -二氟脫氧胞嘧啶核苷聯合卡鉑治療出現的有效率可與紫杉醇聯合卡鉑的治療結果相比，而且有「更可接受的毒性資料」 。
  9. Carboplatin is one of the most important anticancer drugs among the second generation of platinum metal - based drugs, and widely used in clinics

    摘要卡鉑是第二代鉑類金屬抗癌藥物最重要的藥物之一，廣泛應用於臨床。
  10. They also differ from combined paclitaxel and carboplatin, where grade 4 alopecia and flushes are uniersally seen and peripheral neurotoxicity, particularly sensory neuropathy, in roughly one third of subjects

    4級不良反應脫發和面部潮紅一般普遍多見，外周神經毒性，特別是感覺神經病變發生率大致為三分之一，這些也與聯合使用紫杉醇和卡鉑不同。
  11. Gemcitabine plus carboplatin was associated with " moderate aderse reactions. " who grade 3 anemia, neutropenia and thrombocytopenia was seen in 7. 6 %, 9. 5 %, and 0 %, respectiely, on day 8, and 15. 5 %, 12. 2 %, and 15. 5 %, respectiely, on day 15

    二氟脫氧胞嘧啶核苷聯合卡鉑給藥伴隨有「適度的副作用。 」世界衛生組織劃分的3級不良反應，貧血，嗜中性白血球減少和血小板減少的發生率，在第8天分別是7 . 6 ， 9 . 5和0 ，在第15天分別是15 . 5 ， 12 . 2和15 . 5 。
分享友人
分享到 Line

分享到臉書